FDA U.S. Agent: Role, Limits, and Common Misunderstandings

An FDA U.S. Agent serves as a communications link—not a regulatory substitute. The role exists to facilitate communication between FDA and foreign medical-device establishments while maintaining clearly defined regulatory responsibilities.

The U.S. Agent Is a Communications Representative

Foreign medical-device establishments that register with FDA must designate a single U.S. Agent. The agent must reside in the United States or maintain a U.S. place of business and serves primarily as an accessible communications link between FDA and the foreign establishment. The designation is made through FDA's registration system and must be confirmed by the proposed agent.

At FDA's request, the U.S. Agent assists with communications, responds to questions concerning devices imported or offered for import, and helps schedule inspections of the foreign establishment. The role becomes particularly important when time zones, language differences, personnel changes, or internal routing delay direct communication.

If FDA cannot contact the foreign establishment directly or expeditiously, information or documents delivered to the U.S. Agent may be treated as though they were delivered directly to the foreign establishment. A capable agent therefore requires reliable escalation procedures, current contact information, and a clear understanding of which matters require immediate attention.

What the U.S. Agent Does Not Do

The title is often misunderstood as creating a broad U.S. regulatory representative. It does not. Appointment as U.S. Agent does not transfer the foreign establishment's regulatory responsibilities, make the agent the device manufacturer, or cause the agent to assume responsibility for the establishment's quality system, device compliance, registration accuracy, or inspection readiness.

The U.S. Agent is not automatically the Initial Importer, Importer of Record, distributor, complaint-handling unit, or Medical Device Reporting contact. FDA also states that the U.S. Agent has no responsibility, solely by virtue of that designation, for adverse-event reporting or submitting 510(k) premarket notifications.

The U.S. Agent Is Separate From Other Regulatory Roles

The U.S. Agent and the Official Correspondent are distinct roles. A foreign establishment may appoint the same person or organization to both positions, but doing so is optional.

Likewise, an organization serving as U.S. Agent may separately provide registration, listing, regulatory, import, complaint-handling, or commercial support under contract. Those additional responsibilities arise from the agreed scope of services and the organization's actual operational activities—not merely from being named as the FDA U.S. Agent.

Integrating the Role Into U.S. Operations

MDD Options can act as FDA U.S. Agent while establishing practical communication and escalation pathways appropriate to the foreign establishment's U.S. activities.

Where broader support is required, the role can be integrated with establishment registration and listing, Initial Importer services, complaint routing, import coordination, and MDD Options' Hybrid distribution model while keeping each regulatory and operational responsibility clearly defined.